INSTABILITY OF EFAVIRENZ METABOLITES IDENTIFIED DURING METHOD DEVELOPMENT AND VALIDATION.
暂无分享,去创建一个
[1] D. Haas,et al. Pharmacogenetics and pharmacokinetics of CNS penetration of efavirenz and its metabolites , 2018, The Journal of antimicrobial chemotherapy.
[2] A. Telenti,et al. In Vivo Profiling and Distribution of Known and Novel Phase I and Phase II Metabolites of Efavirenz in Plasma, Urine, and Cerebrospinal Fluid , 2016, Drug Metabolism and Disposition.
[3] R. Altman,et al. PharmGKB summary: Efavirenz pathway, pharmacokinetics , 2015, Pharmacogenetics and genomics.
[4] M. Ashton,et al. A rapid and selective HPLC-UV method for the quantitation of efavirenz in plasma from patients on concurrent HIV/AIDS and tuberculosis treatments. , 2013, Biomedical chromatography : BMC.
[5] G. Maartens,et al. Neuronal toxicity of efavirenz: a systematic review , 2013, Expert opinion on drug safety.
[6] J. Barrett,et al. A Sensitive and Selective Liquid Chromatography/Tandem Mass Spectrometry Method for Quantitative Analysis of Efavirenz in Human Plasma , 2013, PloS one.
[7] Edward J. Mills,et al. Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy: a systematic review and meta-analysis , 2013, AIDS.
[8] C. Hendrix,et al. Compartmentalization and Antiviral Effect of Efavirenz Metabolites in Blood Plasma, Seminal Plasma, and Cerebrospinal Fluid , 2013, Drug Metabolism and Disposition.
[9] J. McArthur,et al. Dendritic Spine Injury Induced by the 8-Hydroxy Metabolite of Efavirenz , 2012, Journal of Pharmacology and Experimental Therapeutics.
[10] Kwang-Hyeon Liu,et al. Rapid and Simultaneous Determination of Efavirenz, 8-Hydroxyefavirenz, and 8,14-Dihydroxyefavirenz Using LC–MS–MS in Human Plasma and Application to Pharmacokinetics in Healthy Volunteers , 2011 .
[11] I. Kanfer,et al. Rapid method for the quantitative determination of efavirenz in human plasma. , 2009, Journal of pharmaceutical and biomedical analysis.
[12] J. Mallolas,et al. Determination of efavirenz in human plasma by high-performance liquid chromatography with ultraviolet detection. , 2001, Journal of chromatography. B, Biomedical sciences and applications.
[13] A. Telenti,et al. Efavirenz Plasma Levels Can Predict Treatment Failure and Central Nervous System Side Effects in Hiv-1-infected Patients , 2022 .
[14] A. Mutlib,et al. Identification and characterization of efavirenz metabolites by liquid chromatography/mass spectrometry and high field NMR: species differences in the metabolism of efavirenz. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[15] J. Ribeiro,et al. Ultra-performance liquid chromatographic method for simultaneous quantification of HIV non-nucleoside reverse transcriptase inhibitors and protease inhibitors in human plasma , 2011 .